Dharminder Chauhan
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Oncology top 0.05%
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 94
- Protein Degradation and Inhibitors 76
- Cell death mechanisms and regulation 27
- Histone Deacetylase Inhibitors Research 24
- Hematology 237
- Multiple Myeloma Research and Treatments 233
- Co-authors
- Kenneth C. Anderson (251 shared papers)Teru Hideshima (214 shared papers)Paul G. Richardson (155 shared papers)Nikhil C. Munshi (131 shared papers)Klaus Podar (103 shared papers)Constantine S. Mitsiades (68 shared papers)Noopur Raje (85 shared papers)Nicholas Mitsiades (38 shared papers)
- Journals
- Blood (190 papers)British Journal of Haematology (21 papers)Oncogene (16 papers)Leukemia (16 papers)Cancer Research (12 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Dharminder Chauhan
357 papers receiving 28.7k citations
Dharminder Chauhan's Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 14.6k
- Oncology 10.4k
- Molecular Biology 19.1k
- Immunology 3.6k
- Genetics 1.7k
Countries citing papers authored by Dharminder Chauhan
This map shows the geographic impact of Dharminder Chauhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharminder Chauhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharminder Chauhan more than expected).
Fields of papers citing papers by Dharminder Chauhan
This network shows the impact of papers produced by Dharminder Chauhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharminder Chauhan. The network helps show where Dharminder Chauhan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dharminder Chauhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 361 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB as a Therapeutic Target in Multiple Myeloma Hit paper breakdown → | 2002 | 783 |
| 2 | Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma Hit paper breakdown → | 2001 | 765 |
| 3 | Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy Hit paper breakdown → | 2000 | 726 |
| 4 | Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Hit paper breakdown → | 2002 | 653 |
| 5 | Molecular sequelae of proteasome inhibition in human multiple myeloma cells Hit paper breakdown → | 2002 | 619 |
| 6 | The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications Hit paper breakdown → | 2003 | 591 |
| 7 | A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib Hit paper breakdown → | 2005 | 591 |
| 8 | Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications Hit paper breakdown → | 2002 | 568 |
| 9 | 2005 | 497 | |
| 10 | 2004 | 497 | |
| 11 | 1996 | 490 | |
| 12 | 2003 | 487 | |
| 13 | 2001 | 468 | |
| 14 | 2003 | 463 | |
| 15 | 2002 | 410 | |
| 16 | 2001 | 405 | |
| 17 | 1993 | 374 | |
| 18 | 1997 | 365 | |
| 19 | 2006 | 357 | |
| 20 | 2001 | 350 |
About Dharminder Chauhan
Dharminder Chauhan is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 361 papers that have together received 29.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (233 papers), Ubiquitin and proteasome pathways (94 papers), Protein Degradation and Inhibitors (76 papers), Peptidase Inhibition and Analysis (59 papers), Immunotherapy and Immune Responses (35 papers), Cancer Mechanisms and Therapy (32 papers), Cell death mechanisms and regulation (27 papers) and Histone Deacetylase Inhibitors Research (24 papers). The work is most often cited by research in Hematology (14.6k citations), Oncology (10.4k citations), Molecular Biology (19.1k citations), Immunology (3.6k citations) and Genetics (1.7k citations). Dharminder Chauhan has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Nikhil C. Munshi, Klaus Podar, Constantine S. Mitsiades, Noopur Raje, Nicholas Mitsiades, Robert Schlossman and Yu‐Tzu Tai. Their work appears in journals such as Blood, British Journal of Haematology, Oncogene, Leukemia and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.